Insider · CIK 0001780088
Barry Ticho
officer
Files at STOK (Stoke Therapeutics, Inc.). First filing Nov 5, 2024, latest Oct 2, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 8
$0 bought, $1.0M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
STOK: Stoke Therapeutics, Inc.
STOKOct 9, 2026 · close 24.74
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 8Weak | Stoke Therapeutics, Inc. | $27k 1,051 shares | -5% | +16% from low-32% from high | |
| 11Weak | Stoke Therapeutics, Inc. | $170k 5,545 shares | -22% | +58% from low-19% from high | |
| 17Weak | Stoke Therapeutics, Inc. | $82k 8,216 shares | -24% | +68% from low-35% from high | |
| 18Weak | Stoke Therapeutics, Inc. | $267k 26,631 shares | -44% | +67% from low-35% from high | |
| 36Weak | Stoke Therapeutics, Inc. | $34k 2,586 shares | -5% | +22% from low-10% from high | |
| 47Moderate | Stoke Therapeutics, Inc. | $178k 13,945 shares | -23% | +18% from low-13% from high | |
| 10Weak | Stoke Therapeutics, Inc. | $121k 10,000 shares | -16% | +7% from low-21% from high | |
| 11Weak | Stoke Therapeutics, Inc. | $127k 10,000 shares | -80% | +13% from low-16% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,051 | $26.16 | $27k | 19,059 | 10 d ago |
| Sep 1, 2026 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -3,945 | $30.51 | $120k | 21,710 | 39 d ago |
| Sep 1, 2026 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,600 | $31.06 | $50k | 20,110 | 39 d ago |
| Jun 2, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,745 | $10.00 | $17k | 32,253 | Jun 4, 2025 |
| Jun 3, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -6,471 | $10.03 | $65k | 25,782 | Jun 4, 2025 |
| May 1, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -3,841 | $10.00 | $38k | 56,788 | May 5, 2025 |
| May 2, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -22,790 | $10.03 | $229k | 33,998 | May 5, 2025 |
| Dec 9, 2024 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock | -2,586 | $12.99 | $34k | 44,746 | Dec 11, 2024 |
| Dec 6, 2024 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock | -13,945 | $12.78 | $178k | 47,332 | Dec 10, 2024 |
| Dec 3, 2024 | STOK Stoke Therapeutics, Inc. | MOption exercise Common Stock | +10,000 | $0.00 | $0 | 61,277 | Dec 5, 2024 |
| Dec 3, 2024 | STOK Stoke Therapeutics, Inc. | AGrant or award Performance Stock Unitsderivative | +20,000 | $0.00 | $0 | 20,000 | Dec 5, 2024 |
| Dec 3, 2024 | STOK Stoke Therapeutics, Inc. | MOption exercise Performance Stock Unitsderivative | -10,000 | $0.00 | $0 | 10,000 | Dec 5, 2024 |
| Dec 1, 2024 | STOK Stoke Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +48,792 | $0.00 | $0 | 51,277 | Dec 3, 2024 |
| Dec 2, 2024 | STOK Stoke Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +10,000 | $0.60 | $6,000 | 61,277 | Dec 3, 2024 |
| Dec 2, 2024 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -10,000 | $12.07 | $121k | 51,277 | Dec 3, 2024 |
| Dec 1, 2024 | STOK Stoke Therapeutics, Inc. | MOption exercise Restricted Stock Unit (RSU)derivative10b5-1 | -48,792 | $0.00 | $0 | 11,981 | Dec 3, 2024 |
| Dec 2, 2024 | STOK Stoke Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 0 | Dec 3, 2024 |
| Nov 1, 2024 | STOK Stoke Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +10,000 | $0.60 | $6,000 | 12,485 | Nov 5, 2024 |
| Nov 1, 2024 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -10,000 | $12.68 | $127k | 2,485 | Nov 5, 2024 |
| Nov 1, 2024 | STOK Stoke Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 10,000 | Nov 5, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.